Renal angiomyolipoma (AML) harboring a missense mutation of TSC2 with copy-neutral loss of heterozygosity (CN-LOH)

References

• Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol. 2010;41:1–15. doi:10.1016/j.humpath.2009.05.011.
   PubMed Web of Science ®Google Scholar
• Eble JN. Angiomyolipoma of kidney. Semin Diagn Pathol. 1998;15:21–40.
   PubMed Web of Science ®Google Scholar
• Bissler JJ, Kingswood JC. Renal angiomyolipomata. Kidney Int. 2004;66:924–934. doi:10.1111/j.1523-1755.2004.00838.x.
   PubMed Web of Science ®Google Scholar
• O’Keefe C, McDevitt MA, Maciejewski JP. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood. 2010;115:2731–2739. doi:10.1182/blood-2009-10-201848.
   PubMed Web of Science ®Google Scholar
• Krueger DA, Northrup H. International Tuberous Sclerosis Complex Consensus G. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:255–265. doi:10.1016/j.pediatrneurol.2013.08.002.
   PubMed Web of Science ®Google Scholar
• Northrup H, Koenig MK, Pearson DA, Au KS. Tuberous sclerosis complex. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al., editors. Seattle (WA): GeneReviews((R)); 1993. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1220/
   Google Scholar
• Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer. 1995;13:295–298. doi:10.1002/gcc.2870130411.
   PubMed Web of Science ®Google Scholar
• Smolarek TA, Wessner LL, McCormack FX, Mylet JC, Menon AG, Henske EP. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet. 1998;62:810–815. doi:10.1086/301804.
   PubMed Web of Science ®Google Scholar
• Pan CC, Chung MY, Ng KF, Liu CY, Wang JS, Chai CY, Huang S-H, Chen P-H, Ho D. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma. J Pathol. 2008;214:387–393. doi:10.1002/path.2289.
   PubMed Web of Science ®Google Scholar
• Qin W, Bajaj V, Malinowska I, Lu X, MacConaill L, Wu CL, Kwiatkowski DJ. Angiomyolipoma have common mutations in TSC2 but no other common genetic events. PLoS One. 2011;6:e24919. doi:10.1371/journal.pone.0024919.
   PubMed Web of Science ®Google Scholar
• Yang HM, Choi HJ, Hong DP, Joo SY, Lee NE, Song JY, Choi Y-L, Lee J, Choi D, Kim B, et al. The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex. Exp Mol Pathol. 2014;97:440–444. doi:10.1016/j.yexmp.2014.09.013.
   PubMed Web of Science ®Google Scholar
• Giannikou K, Malinowska IA, Pugh TJ, Yan R, Tseng YY, Oh C, Kim J, Tyburczy ME, Chekaluk Y, Liu Y, et al. Whole exome sequencing identifies TSC1/TSC2 Biallelic loss as the primary and sufficient driver event for renal angiomyolipoma development. PLoS Genet. 2016;12:e1006242. doi:10.1371/journal.pgen.1006242.
   PubMed Web of Science ®Google Scholar
• Pal R, Xiong Y, Sardiello M. Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1-dependent and -independent signaling pathways. Proc Natl Acad Sci U S A. 2019;116:2977–2986. doi:10.1073/pnas.1812943116.
   PubMed Web of Science ®Google Scholar
• Zhang J, Kim J, Alexander A, Cai S, Tripathi DN, Dere R, Tee AR, Tait-Mulder J, Di Nardo A, Han JM, et al. A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS. Nat Cell Biol. 2013;15:1186–1196. doi:10.1038/ncb2822.
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Wakisaka A, Daido S, Takao S, Tamiya T, Date I, Koizumi S, Niida Y. A case of solitary subependymal giant cell astrocytoma: two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism. J Mol Diagn. 2005;7:544–549. doi:10.1016/S1525-1578(10)60586-7.
   PubMed Web of Science ®Google Scholar
• Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357–360. doi:10.1038/nmeth.3317.
   PubMed Web of Science ®Google Scholar
• Ohashi T, Idogawa M, Sasaki Y, Tokino T. p53 mediates the suppression of cancer cell invasion by inducing LIMA1/EPLIN. Cancer Lett. 2017;390:58–66. doi:10.1016/j.canlet.2016.12.034.
   PubMed Web of Science ®Google Scholar
• Idogawa M, Ohashi T, Sasaki Y, Nakase H, Tokino T. Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function. Int J Cancer. 2017;140:2785–2791. doi:10.1002/ijc.v140.12.
   PubMed Web of Science ®Google Scholar
• Idogawa M, Nakase H, Sasaki Y, Tokino T. Prognostic effect of long noncoding RNA NEAT1 expression depends on p53 mutation status in cancer. J Oncol. 2019;2019:4368068. doi:10.1155/2019/4368068.
   PubMed Web of Science ®Google Scholar
• Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22:568–576. doi:10.1101/gr.129684.111.
   PubMed Web of Science ®Google Scholar
• Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164. doi:10.1093/nar/gkq603.
   PubMed Web of Science ®Google Scholar